Picture of Orior AG logo

ORON Orior AG News Story

0.000.00%
ch flag iconLast trade - 00:00
Consumer DefensivesSpeculativeSmall CapSuper Stock

Swiss stocks - Factors to watch on April 9

ZURICH/BERLIN, April 9 (Reuters) - Here are some of the main
factors that may affect Swiss stocks on Thursday:
    
    CORONAVIRUS
    Switzerland plans to ease restrictions now in place to
combat the new coronavirus starting at the end of April, the
government said on Wednesday, adding the economic damage from
the epidemic could be the worst on record.  urn:newsml:reuters.com:*:nL8N2BW5KI
    
    BANKS
    Switzerland's two big banks, UBS  UBSG.S  and Credit Suisse
 CSGN.S , said they decided to pay out part of their dividend
for 2019 later this year after financial markets watchdog FINMA
had criticised their decision to maintain a full payout during
the coronavirus crisis.  urn:newsml:reuters.com:*:nL5N2BX0E7
    Swiss financial watchdog Finma said on Thursday it welcomed
a decision by UBS and Credit Suisse to pay out half of their
dividends for 2019 in the fourth quarter of 2020 despite their
strong capital decisions.  urn:newsml:reuters.com:*:nS8N2BH02G
    
    COMPANY STATEMENTS
    * Bobst Group  BOBNN.S : On 8 April 2020, Bobst acquired a
majority participation of 51% in Cito-System.
    * Santhera Pharmaceuticals Holding AG  SANN.S  completed a
capital increase to create shares for Iris. It said it expected
to use the shares under equity-linked financing provided by
Iris.
    * Basilea Pharmaceutica AG  BSLN.S  said it saw no
indication of negative impact on prescriptions for Cresemba,
Zevtera.
    * Hbm Healthcare Investments AG  HBMN.S  said HBM portfolio
company Arrakis Therapeutics entered a strategic collaboration
and license agreement with Roche  ROG.S 
    * Orior AG  ORON.S  said reliable projections of course of
business in 2020 are not possible due to current uncertainties.
    * Kuehne und Nagel International  KNIN.S  said it proposed
not to resolve dividend due to Covid-19 pandemic impact.
    
    
    ANALYSTS' VIEWS
    * SWISS RE AG  SRENH.S : JP MORGAN CUTS TARGET PRICE TO CHF
98 FROM CHF 108 
    * JULIUS BAER GRUPPE AG  BAER.S : CREDIT SUISSE CUTS TARGET
PRICE TO CHF 49.50 FROM CHF 58.50
    * UBS GROUP AG  UBSG.S : CREDIT SUISSE CUTS TARGET PRICE TO
CHF 13.50 FROM CHF 16
    
        
    ECONOMY
    No major economic data scheduled.

 (Reporting by Zurich newsroom and Berlin Speed Desk)
 ((+41 58 306 7336; zurich.newsroom@thomsonreuters.com))
 
((For Top News in a multimedia Web format on Eikon visit: https://bit.ly/2NDFd6g
FOR RELATED PRICES, NEWS AND OTHER TOPICS, DOUBLE-CLICK ON:
Daily Swiss stock market report in German  .SDE 
All SMI constituent stocks  0#.SSMI 
DJ STOXX index  .STOXX 
Top 10 STOXX sectors  .PGL.STOXXS 
Top 10 EUROSTOXX sectors  .PGL.STOXXES 
Swiss mid-cap index  .SSMI 
Swiss all-share index  .SSHI 
Swiss market digest  .AD.S 
Sector overview  CH/SECTOR1 
All Swiss news  CH 
Swiss research news  CH-RCH   
All equity news  E 
SPEED GUIDES:   EQUITY   EQUITY/NEWS1   EUR/EQUITY   SWITZERLAND   REUTERS  ))

Recent news on Orior AG

See all news